Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

TherapeuticsMD Inc

TXMD ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: N/A

Last Close

$2.07

▼ -0.48%

Market Cap $23.96M · Vol 6.47K

Key Metrics

P/E Ratio

280.11

FWD: N/A

Market Cap

$23.96M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

0.64

vs Market

52W High

$2.93

29.35% below

52W Low

$1.00

107.00% above

Volume

6.47K

Avg 5.35K

P/B

0.70

Price-to-book

ROE

N/A

Return on equity

Free Float

90.96%

Public shares

Shariah Compliance8 STANDARDS

✗ TherapeuticsMD Inc (TXMD) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TXMD pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

+5.08%

+4.02%

-12.29%

YTD

+26.99%

+76.92%

-46.09%

-95.19%

Financials & Valuation

TTM · Annual

Total Revenue	$3.02M
Net Income	$-653,000.00
Revenue Growth (YoY)	-8.72%
Gross Margin	100.00%
Operating Margin	-139.44%
Net Profit Margin	-21.61%
ROE	N/A
ROA · ROIC	-1.71% · N/A

P/E Ratio	280.11
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	6.24
P/B	0.70
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	11.57M

Technical Indicators

50-Day SMA	$2.05
200-Day SMA	$2.01
RSI (14)	50.00
Beta	0.64
52-Week High	$2.93
52-Week Low	$1.00

Volume Today	6.47K
Avg Daily Volume (30D)	5.35K
Relative Volume	1.21x
Volatility (10D)	10.38
Volatility (30D)	30.47
Free Float	90.96%

Analyst Consensus

N/A

Current Price $2.07

Mean Target N/A

52W Low$1.00 52W High$2.93

Current

Target

$1.00 $2.93

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SDVKL6

ISINUS88338N2062

CountryUnited States of America

Sub-IndustryProprietary & Advanced Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

MRK Merck & Co Inc +0.21% MRK.DE Merck KGaA -2.29% HALO Halozyme Therapeutics Inc -2.00% 4151.T Kyowa Kirin Co Ltd -1.26% 326030.KS SK Biopharmaceuticals Co Ltd -0.34%

Company Profile

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).